Patents

• Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors. WO 11/058113
• Fused bicyclic pyrazole derivatives as kinase inhibitors. WO 11/058112
• Aminopurine derivatives as kinase inhibitors. WO 11/058111
• Quinoline and quinoxaline derivatives as kinase inhibitors. WO 11/058110
• Fused bicyclic pyrrole and imidazole derivatives as kinase inhibitors WO 11/058109
• Quinoline and quinoxaline derivatives as kinase inhibitors. WO 11/058108.
• Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurogenerative diseases. WO 2011/015573
• Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurogenerative diseases. WO 2011/015572
• Pyrazole oxadiazole derivatives as S1P1 agonists. WO 2010/142628
• Fused bicyclic pyrazole derivatives as kinase inhibitors. WO 2010/133836
• Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives. WO 2010/123933
• Compounds, compositions and methods comprising pyridazine sulphonamide derivatives. WO 2010/123822
• Methods and means for treatment of osteoarthritis. WO 2010/115841
• Preparation of triazines as phosphoinositide 3-kinase (PI3K) inhibitors. WO 10/100405
• Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation. WO 2010/094734
• Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation. WO 2010/094733
• Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation. WO 2010/094732
• Fused pyridine and pyrazine derivatives as kinase inhibitors. WO 10/092340.
• Preparation of fused pyrazines as phosphoinositide 3-kinase (PI3K) inhibitors. WO 10/052448
• Compounds, compositions and methods comprising imidazole and triazole derivatives. WO 2010/033626
• Thienopyrimidines for pharmaceutical compositions. WO/2010/023181.
• Novel compounds useful for the treatment of degenerative and inflammatory diseases. WO 2010/010190.
• Novel compounds useful for the treatment of degenerative and inflammatory diseases. WO 2010/010189.
• Novel compounds useful for the treatment of degenerative and inflammatory diseases. WO 2010/010188.
• [1, 2, 4] triazolo [1, 5-a] pyridines as JAK inhibitors. WO 2010/010184.
• High-throughput cell-based CFTR assay.  WO 2009/131948.
• Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents. WO 2009/138796.
• Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases. WO 2009/138794.
• Substituted quinazolines. WO 2009/138792.
• Substituted quinazolines as blood platelet lowering agents. WO 2009/138789.
• Substituted quinazolines. WO 2009/138788.
• Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases. WO 2009/135885.
• Compounds, compositions and methods comprising triazine derivatives. WO/2009/131958.
• Compounds, compositions and methods comprising oxadiazole derivatives. WO/2009/131957.
• Compounds, compositions and methods comprising triazole derivatives. WO/2009/131956.
• Compounds, compositions and methods comprising oxadiazole derivatives. WO/2009/131954.
• Compounds, compositions and methods comprising thiazole derivatives. WO/2009/131952.
• Compounds, compositions and methods comprising isoxazole derivatives. WO/2009/131951.
• Compounds, compositions and methods comprising pyridazine derivatives. WO/2009/131947.
• Triazolopyridine compounds and their use as ASK inhibitors. WO 2009/027283.
• Quinoxaline and quinoline derivatives as kinase inhibitors. WO 2009/081105.
• Imidazo [1,2-a] pyrazine compounds for treatment of viral infections such as hepatitis. WO 2009/024585.
• Imidazopyridines and triazolopyrimidines useful for the treatment of joint degenerative & inflammatory diseases. WO 2008/138843.
• Imidazopyrazines and triazolopyrazine for the treatment of joint degenerative and inflammatory diseases. WO 2008/138842.
• 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases. WO 2008/129080.
• CFTR inhibitor compounds and uses thereof. WO 2008/121877.
• Quinolinone derivatives as parp and tank inhibitors. WO 2008/107478.
• Pyridine benzamides and pyrazine benzamides used as PKD inhibitors. WO 2008/074997.
• Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases. WO 2008/065199.
• Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases. WO 2008/065198.
• Novel compounds useful for the treatment of degenerative & inflammatory diseases. WO 2008/055959.
• Antibacterial compositions. WO 2007/148093.
• Novel n-aryl and n-heteroaryl substituted pyridinone derivatives for use in MCH-1 mediated diseases. WO 2007/141200.
• Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases. WO 2007/138072.
• Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases. WO 2007/131991.
• Trisubstituted 1,2,4-triazoles. WO 2007/118903.
• Pyridine-, isoxazole, thiophenecarboxamide compounds having activity at the glycine transporter GlyT1 and uses thereof. WO 2007/080159.
• Novel substituted pyrazinone derivatives for use in MCH-1 mediated diseases. WO 2007/071646.
• Tricyclic spiro derivatives as CRTH2 modulators. WO 2006/125784.
• Piperazine derivatives as GlyT1 inhibitors. WO 2006/094843.
• Acylated piperidihes as glycine transporter inhibitors. WO 2006/094842.
• Compounds. WO 2006/094840.
• Compounds which bind to the active site of protein kinase enzymes. WO 2006/072792.
• Oxygen containing heterocycles as glycine transporter inhibiting compounds. WO 2006/067437.
• 2-amino-1-phenylethylcarboxamide derivatives. WO 2006/067430.
• Glycine transport inhibitors. WO 2006/067423.
• Glycine transport inhibitors. WO 2006/067417.
• Glycine transport inhibitors. WO 2006/067414.
• Compounds. WO 2006/061642.
• Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes. WO 2006/051311.
• Pyrazolo[1,5-a]pyrimidine derivative. WO 2006/016715.
• Pyridinylamines. WO 2006/010637.
• Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases. WO 2005/026129.

Bookmark with:

del.icio.us Digg Reddit Facebook Stumbleupon Twitter LinkedIn What are these?